Skip to main content

and
  1. Article

    Open Access

    SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict a metastatic pattern in pT3a prostate cancer

    Recently, we introduced Stroma-AReactive-Invasion-Front-Areas (SARIFA) as a novel hematoxylin–eosin (H&E)-based histopathologic prognostic biomarker for various gastrointestinal cancers, closely related to lip...

    Johanna S. Enke, Matthias Groß, Bianca Grosser, Eva Sipos, Julie Steinestel in BMC Cancer (2024)

  2. Article

    Open Access

    Co-expression and clinical utility of AR-FL and AR splice variants AR-V3, AR-V7 and AR-V9 in prostate cancer

    Androgen receptor (AR) splice variants (AR-Vs) have been discussed as a biomarker in prostate cancer (PC). However, some reports question the predictive property of AR-Vs. From a mechanistic perspective, the c...

    Neele Wüstmann, Konstantin Seitzer, Verena Humberg, Julia Vieler in Biomarker Research (2023)

  3. Article

    Open Access

    Comparison of circulating tumor cells and AR-V7 as clinical biomarker in metastatic castration-resistant prostate cancer patients

    Biomarker in metastatic castration resistant prostate cancer (mCRPC) treatment are rare. We aimed to compare the clinical value of circulating tumor cells (CTCs) and androgen receptor splice variant 7 (AR-V7) ...

    Katrin Schlack, Konstantin Seitzer, Neele Wüstmann, Verena Humberg in Scientific Reports (2022)

  4. No Access

    Article

    Novel AR-V7 detection in whole blood samples in patients with prostate cancer: not as simple as it seems

    Christof Bernemann, Julie Steinestel, Martin Boegemann in World Journal of Urology (2017)

  5. No Access

    Article

    The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cells

    Metastasis is the survival-determining factor in urothelial carcinoma (UC) of the urinary bladder. The small conductance calcium-activated potassium channel 3 (SK3) enhances tumor cell invasion in breast cance...

    Konrad Steinestel, Stefan Eder, Konstantin Ehinger, Juliane Schneider in Tumor Biology (2016)

  6. Article

    Erratum to: The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cells

    Konrad Steinestel, Stefan Eder, Konstantin Ehinger, Juliane Schneider in Tumor Biology (2016)

  7. No Access

    Article

    Serum 17β-estradiol fails as a marker in identification of aggressive tumour disease in patients with localized prostate cancer

    There is evidence that obesity is associated with an aggressive prostate cancer (PC). Furthermore, preclinical studies suggest that oestrogens may play a pivotal role in this context. The biological processes ...

    Thomas J. Schnoeller, Julie Steinestel, Friedemann Zengerling in World Journal of Urology (2015)

  8. No Access

    Article

    Do preoperative serum C-reactive protein levels predict the definitive pathological stage in patients with clinically localized prostate cancer?

    The serum C-reactive protein (CRP) level correlates with the clinical prognosis in patients with kidney, penile and metastatic castration-resistant prostate cancer (PC). We prospectively evaluated the preopera...

    Thomas J. Schnoeller, Julie Steinestel in International Urology and Nephrology (2015)

  9. Article

    Open Access

    The role of histologic subtype, p16INK4a expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma

    Up to 50% of penile squamous cell carcinomas (pSCC) develop in the context of high-risk human papillomavirus (HR-HPV) infection. Most of these tumours have been reported to show basaloid differentiation and ov...

    Julie Steinestel, Andreas Al Ghazal, Annette Arndt, Thomas J Schnoeller in BMC Cancer (2015)

  10. No Access

    Article

    Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor size

    Chromophobe renal cell carcinoma (chRCC) is the third most common subtype of RCC, after clear cell (ccRCC) and papillary RCC. Its lower incidence and frequent exclusion from clinical trials might be why chRCC ...

    Sandra Steffens, Frederik C. Roos, Martin Janssen, Frank Becker in Virchows Archiv (2014)

  11. Article

    Open Access

    Positive surgical margins in nephron-sparing surgery: risk factors and therapeutic consequences

    The increased use of nephron-sparing surgery to treat localized renal cell carcinoma (RCC) lends weight to the question of the value of microscopically positive surgical margins (PSM) in cases with a tumor bed...

    Julie Steinestel, Sandra Steffens, Konrad Steinestel in World Journal of Surgical Oncology (2014)

  12. Article

    Open Access

    Clinical significance of epithelial-mesenchymal transition

    The concept of epithelial-mesenchymal transition (EMT), a process where cells change their epithelial towards a mesenchymal phenotype, has gained overwhelming attention especially in the cancer research commun...

    Konrad Steinestel, Stefan Eder, Andres Jan Schrader in Clinical and Translational Medicine (2014)

  13. Article

    Open Access

    Expression and Y435-phosphorylation of Abelson interactor 1 (Abi1) promotes tumour cell adhesion, extracellular matrix degradation and invasion by colorectal carcinoma cells

    The Abelson tyrosine kinase (c-Abl) inhibitor STI571 (Glivec®) has been shown to effectively inhibit colorectal cancer cell migration and invasion. The c-Abl substrate abelson interactor 1 (Abi1) is a key regu...

    Konrad Steinestel, Silke Brüderlein, Jochen K Lennerz, Julie Steinestel in Molecular Cancer (2014)

  14. Article

    Open Access

    Survival advantage of partial over radical nephrectomy in patients presenting with localized renal cell carcinoma

    Partial nephrectomy (PN) preserves renal function and has become the standard approach for T1a renal cell carcinoma (RCC). However, there is still an ongoing debate as to which patients will actually derive gr...

    Frederik C Roos, Sandra Steffens, Kerstin Junker, Martin Janssen in BMC Cancer (2014)

  15. Article

    Open Access

    Elevated C-reactive protein values predict nodal metastasis in patients with penile cancer

    The nodal status is a strong predictor for cancer specific death in patients with penile carcinoma, and the C-reactive protein (CRP) level at diagnosis has recently been shown to be associated with poor clinic...

    Andreas Al Ghazal, Sandra Steffens, Julie Steinestel, Rieke Lehmann in BMC Urology (2013)

  16. Article

    Open Access

    High CRP values predict poor survival in patients with penile cancer

    High levels of circulating C-reactive protein (CRP) have recently been linked to poor clinical outcome in various malignancies. The aim of this study was to evaluate the prognostic significance of the preopera...

    Sandra Steffens, Andreas Al Ghazal, Julie Steinestel, Rieke Lehmann in BMC Cancer (2013)